title: Nanomechanics of drug-target interactions and antibacterial resistance detection.
abstract: The cantilever sensor, which acts as a transducer of reactions between model bacterial cell wall matrix immobilized on its surface and antibiotic drugs in solution, has shown considerable potential in biochemical sensing applications with unprecedented sensitivity and specificity. The drug-target interactions generate surface stress, causing the cantilever to bend, and the signal can be analyzed optically when it is illuminated by a laser. The change in surface stress measured with nano-scale precision allows disruptions of the biomechanics of model bacterial cell wall targets to be tracked in real time. Despite offering considerable advantages, multiple cantilever sensor arrays have never been applied in quantifying drug-target binding interactions. Here, we report on the use of silicon multiple cantilever arrays coated with alkanethiol self-assembled monolayers mimicking bacterial cell wall matrix to quantitatively study antibiotic binding interactions. To understand the impact of vancomycin on the mechanics of bacterial cell wall structures. We developed a new model(1) which proposes that cantilever bending can be described by two independent factors; i) namely a chemical factor, which is given by a classical Langmuir adsorption isotherm, from which we calculate the thermodynamic equilibrium dissociation constant (Kd) and ii) a geometrical factor, essentially a measure of how bacterial peptide receptors are distributed on the cantilever surface. The surface distribution of peptide receptors (p) is used to investigate the dependence of geometry and ligand loading. It is shown that a threshold value of p ~10% is critical to sensing applications. Below which there is no detectable bending signal while above this value, the bending signal increases almost linearly, revealing that stress is a product of a local chemical binding factor and a geometrical factor combined by the mechanical connectivity of reacted regions and provides a new paradigm for design of powerful agents to combat superbug infections.
authors.affiliation: London Centre for Nanotechnology and Departments of Medicine, University College London.
authors.forename: Joseph W
authors.initials: JW
authors.lastname: Ndieyira
authors.forename: Moyu
authors.initials: M
authors.lastname: Watari
authors.forename: Rachel A
authors.initials: RA
authors.lastname: McKendry
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D001419:Bacteria / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D040761:Biomimetic Materials / Q000737:chemistry; D015374:Biosensing Techniques / Q000379:methods; D002473:Cell Wall / Q000187:drug effects / Q000378:metabolism; D024901:Drug Resistance, Multiple, Bacterial; D057166:High-Throughput Screening Assays / Q000379:methods; D008826:Microbial Sensitivity Tests; D012825:Silicon / Q000737:chemistry; D013816:Thermodynamics; D014640:Vancomycin / Q000737:chemistry / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D012825:Silicon